GLP-3 (RT)

Full name: GLP-Rt (LY3437943)

GLP-Rt is an investigational triple hormone-receptor agonist that activates the GIP, GLP-1, and glucagon receptors. It is being studied as a potential treatment for obesity and related metabolic conditions. In a Phase 2 clinical trial, GLP-Rt produced substantial reductions in body weight over 48 weeks. 

Key benefits / areas of research:

• Investigated for body-weight reduction
• Studied for obesity management
• Research into metabolic health
• Targets three hormonal pathways: GIP, GLP-1, and glucagon
• Investigated for effects on energy balance and appetite regulation
• Research interest in glycemic and metabolic parameters
• Being studied across multiple clinical-development programs